• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用住院和药物处方数据比较澳大利亚水痘和带状疱疹疫苗接种前的疾病负担。

Use of hospitalization and pharmaceutical prescribing data to compare the prevaccination burden of varicella and herpes zoster in Australia.

作者信息

MacIntyre C R, Chu C P, Burgess M A

机构信息

National Center for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Children's Hospital at Westmead, Westmead, NSW, Australia 2145.

出版信息

Epidemiol Infect. 2003 Aug;131(1):675-82. doi: 10.1017/s0950268803008690.

DOI:10.1017/s0950268803008690
PMID:12948367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2870008/
Abstract

The aims of the study were to compare the burden of varicella and herpes zoster in Australia. No national surveillance exists for varicella or herpes zoster. We used hospital morbidity data from 1993-9 and pharmaceutical prescribing data from 1995-9. In the financial year 1998/99, there were 4718 hospitalizations for zoster compared to 1991 for varicella. For varicella the mean age of patients was 15 years compared to 69 years for zoster. The mean length of stay in hospital was 4.2 days for varicella and 12.7 days for zoster. Varicella accounted for 8396 (3726 with principal diagnosis varicella) bed days compared to 26 266 (5382 with principal diagnosis of zoster) for zoster. The in-hospital case-fatality rate was 0.4% for varicella and 1% for zoster. In 1999, 59 200 community-based cases of zoster were treated with antivirals. We estimate that 157 266 cases of zoster occurred in the community in 1999, a rate of 830 per 100 000 population. Herpes zoster has a higher burden of disease than varicella, and must be a component of disease surveillance in order to determine the full impact of vaccination on the epidemiology of varicella zoster virus (VZV).

摘要

该研究的目的是比较澳大利亚水痘和带状疱疹的疾病负担。目前尚无针对水痘或带状疱疹的全国性监测。我们使用了1993 - 1999年的医院发病率数据以及1995 - 1999年的药品处方数据。在1998/1999财政年度,带状疱疹住院患者有4718例,而水痘为1991例。水痘患者的平均年龄为15岁,带状疱疹患者为69岁。水痘患者的平均住院天数为4.2天,带状疱疹患者为12.7天。水痘占8396个床日(主要诊断为水痘的有3726个),而带状疱疹占26266个床日(主要诊断为带状疱疹的有5382个)。水痘的院内病死率为0.4%,带状疱疹为1%。1999年,59200例社区带状疱疹病例接受了抗病毒治疗。我们估计1999年社区中发生了157266例带状疱疹病例,发病率为每10万人口830例。带状疱疹的疾病负担高于水痘,并且必须成为疾病监测的一部分,以便确定疫苗接种对水痘带状疱疹病毒(VZV)流行病学的全面影响。

相似文献

1
Use of hospitalization and pharmaceutical prescribing data to compare the prevaccination burden of varicella and herpes zoster in Australia.利用住院和药物处方数据比较澳大利亚水痘和带状疱疹疫苗接种前的疾病负担。
Epidemiol Infect. 2003 Aug;131(1):675-82. doi: 10.1017/s0950268803008690.
2
The burden of hospitalisation for varicella and herpes zoster in England from 2004 to 2013.2004 年至 2013 年期间英国水痘和带状疱疹住院负担。
J Infect. 2016 Sep;73(3):241-53. doi: 10.1016/j.jinf.2016.05.008. Epub 2016 Jun 7.
3
Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States.美国水痘疫苗引入前后带状疱疹相关的住院情况及费用支出。
Infect Control Hosp Epidemiol. 2008 Dec;29(12):1157-63. doi: 10.1086/591975.
4
Different vaccination strategies in Spain and its impact on severe varicella and zoster.西班牙的不同疫苗接种策略及其对严重水痘和带状疱疹的影响。
Vaccine. 2014 Jan 3;32(2):277-83. doi: 10.1016/j.vaccine.2013.11.008. Epub 2013 Nov 22.
5
Epidemiology of Varicella-Zoster Virus in England and Wales.英格兰和威尔士水痘带状疱疹病毒的流行病学
J Med Virol. 2003;70 Suppl 1:S9-14. doi: 10.1002/jmv.10313.
6
Early impact of universal varicella vaccination on childhood varicella and herpes zoster hospitalizations in Brazil.巴西水痘和带状疱疹住院治疗的普遍水痘疫苗接种的早期影响。
Vaccine. 2018 Jan 4;36(2):280-284. doi: 10.1016/j.vaccine.2017.11.057. Epub 2017 Dec 1.
7
The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.荷兰水痘和带状疱疹的流行病学:对水痘带状疱疹病毒疫苗接种的影响。
Vaccine. 2006 May 1;24(18):3946-52. doi: 10.1016/j.vaccine.2006.02.017. Epub 2006 Feb 24.
8
Trends in U.S. Community hospitalizations due to herpes zoster: 2001-2015.美国社区带状疱疹住院治疗趋势:2001-2015 年。
Vaccine. 2019 Feb 4;37(6):882-888. doi: 10.1016/j.vaccine.2018.12.034. Epub 2019 Jan 4.
9
[Modelling the impact of vaccination on the epidemiology of varicella zoster virus].[模拟疫苗接种对水痘带状疱疹病毒流行病学的影响]
Rev Epidemiol Sante Publique. 2008 Oct;56(5):323-31. doi: 10.1016/j.respe.2008.07.087. Epub 2008 Oct 31.
10
Epidemiology of primary varicella and herpes zoster hospitalizations: the pre-varicella vaccine era.原发性水痘和带状疱疹住院的流行病学:水痘疫苗接种前时代
J Infect Dis. 2000 Jun;181(6):1897-905. doi: 10.1086/315492. Epub 2000 Jun 5.

引用本文的文献

1
A systematic literature review of the epidemiology and burden of herpes zoster in selected locales in Asia Pacific.亚太地区部分地区带状疱疹的流行病学和疾病负担的系统文献回顾。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2344983. doi: 10.1080/21645515.2024.2344983. Epub 2024 May 20.
2
Global Prevalence of Varicella-Associated Complications: A Systematic Review and Meta-Analysis.水痘相关并发症的全球患病率:系统评价与荟萃分析
Infect Dis Ther. 2024 Jan;13(1):79-103. doi: 10.1007/s40121-023-00899-7. Epub 2023 Dec 19.
3
Burden of Herpes Zoster in Individuals with Immunocompromised Conditions and Autoimmune Diseases in the Republic of Korea: A Nationwide Population-Based Database Study.韩国免疫功能低下者和自身免疫性疾病患者带状疱疹负担:一项基于全国人口数据库的研究。
Infect Dis Ther. 2023 Dec;12(12):2771-2790. doi: 10.1007/s40121-023-00894-y. Epub 2023 Dec 12.
4
Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific.回首往昔,展望未来:亚太地区带状疱疹二十年审计报告
BMC Infect Dis. 2017 Mar 15;17(1):213. doi: 10.1186/s12879-017-2198-y.
5
Herpes zoster-associated mortality in Europe: a systematic review.欧洲带状疱疹相关死亡率:一项系统综述。
BMC Public Health. 2015 May 5;15:466. doi: 10.1186/s12889-015-1753-y.
6
Increasing trends of herpes zoster in Australia.澳大利亚带状疱疹呈上升趋势。
PLoS One. 2015 Apr 30;10(4):e0125025. doi: 10.1371/journal.pone.0125025. eCollection 2015.
7
Risk factors for herpes zoster in a large cohort of unvaccinated older adults: a prospective cohort study.一大群未接种疫苗的老年人中带状疱疹的危险因素:一项前瞻性队列研究。
Epidemiol Infect. 2015 Oct;143(13):2871-81. doi: 10.1017/S0950268814003653. Epub 2015 Jan 16.
8
Systematic review of incidence and complications of herpes zoster: towards a global perspective.带状疱疹发病率及并发症的系统评价:全球视角
BMJ Open. 2014 Jun 10;4(6):e004833. doi: 10.1136/bmjopen-2014-004833.
9
Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany.德国带状疱疹和带状疱疹后神经痛的流行病学和成本。
Eur J Health Econ. 2013 Dec;14(6):1015-26. doi: 10.1007/s10198-012-0452-1. Epub 2012 Dec 28.
10
Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient.带状疱疹及带状疱疹后神经痛:老年患者的优化管理
Drugs Aging. 2008;25(12):991-1006. doi: 10.2165/0002512-200825120-00002.